Dried plasma project

Helse Bergen has received 15 million NOK in funding from Innovation Norway to develop technology for local production of dried plasma. This gives Helse Bergen an unique opportunity to produce dried blood plasma which can be distributed to prehospital health care providers and ambulances, hospitals, the municipal health service and military health services. This technology is of interest both on a national and international level.

Early blood plasma transfusion reduces mortality in patients with severe bleeding. It is therefore important to ensure availability of blood plasma at all treatment levels, including prehospital health services. This can be achieved by use of dried plasma.

Production of dried plasma at the blood banks will enable a stable supply of a life-saving product. In addition, we will have the flexibility to adjust the production to needs in an emergency.

We have therefore, after market dialogue and tender competition, found a norwegian supplier who will develop instruments to produce dried blood plasma: Norsk Frysetørking AS. The manufacturer has extensive experience with freeze-drying nutrients and animal feed, and much of this experience can be transferred to drying blood plasma.

The project is now in a development phase. Norsk Frysetørking AS is developing, in collaboration with Helse Bergen and the reference group, the pilot instrument and production line for dried blood plasma. To ensure that the new product meets the requirements and wishes from blood banks and clinicians, user meetings are regularly held where the end product is demonstrated and discussed.

Aim of project:

Local production of dried blood plasma for delivery to Bergen Hospital Trust and Norwegian and Nordic partners.

For more information, please contact nokblod@helse-bergen.no

For information in Norwegian: Haukeland skal sikre at blodbankane i Noreg kan produsere eigen tørka blodplasma